1. Home
  2. GRFS vs VNT Comparison

GRFS vs VNT Comparison

Compare GRFS & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • VNT
  • Stock Information
  • Founded
  • GRFS 1940
  • VNT 2019
  • Country
  • GRFS Spain
  • VNT United States
  • Employees
  • GRFS N/A
  • VNT N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • VNT Industrial Machinery/Components
  • Sector
  • GRFS Health Care
  • VNT Industrials
  • Exchange
  • GRFS Nasdaq
  • VNT Nasdaq
  • Market Cap
  • GRFS 5.1B
  • VNT 5.9B
  • IPO Year
  • GRFS 2006
  • VNT N/A
  • Fundamental
  • Price
  • GRFS $7.72
  • VNT $32.10
  • Analyst Decision
  • GRFS Strong Sell
  • VNT Buy
  • Analyst Count
  • GRFS 1
  • VNT 7
  • Target Price
  • GRFS N/A
  • VNT $44.00
  • AVG Volume (30 Days)
  • GRFS 1.4M
  • VNT 1.4M
  • Earning Date
  • GRFS 01-01-0001
  • VNT 05-01-2025
  • Dividend Yield
  • GRFS N/A
  • VNT 0.31%
  • EPS Growth
  • GRFS 283.33
  • VNT 13.64
  • EPS
  • GRFS 0.24
  • VNT 2.75
  • Revenue
  • GRFS $7,467,006,939.00
  • VNT $2,979,000,000.00
  • Revenue This Year
  • GRFS $8.45
  • VNT $2.65
  • Revenue Next Year
  • GRFS $7.08
  • VNT $4.77
  • P/E Ratio
  • GRFS $38.73
  • VNT $11.93
  • Revenue Growth
  • GRFS 9.41
  • VNT N/A
  • 52 Week Low
  • GRFS $5.68
  • VNT $31.22
  • 52 Week High
  • GRFS $9.96
  • VNT $45.62
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 48.63
  • VNT 24.37
  • Support Level
  • GRFS $7.36
  • VNT $32.09
  • Resistance Level
  • GRFS $7.96
  • VNT $33.30
  • Average True Range (ATR)
  • GRFS 0.44
  • VNT 1.06
  • MACD
  • GRFS -0.06
  • VNT -0.52
  • Stochastic Oscillator
  • GRFS 39.11
  • VNT 4.63

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2023.

Share on Social Networks: